Happy-People-Pills for All

Authors

  • Mark Walker Department of Philosophy New Mexico State University P.O. Box 30001, MSC 3B Las Cruces, NM 88003-8001 http://www.nmsu.edu/~philos/mark-walkers-home-page.html

Keywords:

wellbeing, well-being, public policy, perfectionism, happiness, happinessism

Abstract

It is argued that we have a moral duty to create, and make available, advanced pharmacological agents to boost the happiness of those in the normal, i.e., the non-depressed, range of happiness. Happiness, conceived as a propensity to positive moods, is a quantitative trait with a sizeable genetic component. One means to boost the happiness of those in the normal range is to test the efficacy of antidepressants for enhancement. A second possibility is to model new pharmacologicals based on the genetics of the happiest amongst us, that is, the hyperthymic. The suggestion, in other words, is to “reverse engineer” the hyperthymic: to investigate what makes the hyperthymic genetically and physiologically different and then put what they have into pill form. To the ‘Brave New World’ objection, that there is more to wellbeing than happiness and that taking happy-people-pills will require the sacrifice of these other aspects of wellbeing, it is countered that contemporary social science research supports the view that happiness promotes achievement in the ‘higher’ endeavors of humanity, including work, love and virtue. In other words, happiness promotes acquisition of traits valued by perfectionists. Those born with genes for hyperthymia, on average, tend to be doubly blessed: they are happier and achieve more than the rest of the population. Happy-people-pills are a means to allow everyone else to share in this good fortune. The paper seeks to rebut two further criticisms: that happy-people-pills will lead to emotional inappropriateness and inauthentic happiness. Finally, it is argued that depending on the view about the role of government in individual welfare, either government has a positive duty to develop happy-people-pills, or government has a duty not to interfere with private companies that seek to develop such pharmacological agents.

Downloads

Download data is not yet available.

Author Biography

Mark Walker, Department of Philosophy New Mexico State University P.O. Box 30001, MSC 3B Las Cruces, NM 88003-8001 http://www.nmsu.edu/~philos/mark-walkers-home-page.html

Philosophy, Assistant Professor

Downloads

Published

2011-01-30

Issue

Vol. 1 No. 1 (2011)

Section

Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial No Derivatives License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. The license prevents others from using the work for profit without the express consent of the author(s). The license also prevents the creation of derivative works without the express consent of the author(s). Note that derivative works are very similar in nature to the original. Merely quoting (and appropriately referencing) a passage of a work is not making a derivative of it.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).